首页|期刊导航|成都中医药大学学报|基于网络药理学和体外试验探讨川芎茎叶苯酞提取物抗缺血性脑卒中的作用机制

基于网络药理学和体外试验探讨川芎茎叶苯酞提取物抗缺血性脑卒中的作用机制OA

Effect of Phthalide Extract from Stems and Leaves of Ligusticum Chuanxiong in Treatment of Ischemic Stroke Based on Net-work Pharmacology and in Vitro Experiments

中文摘要英文摘要

目的:基于网络药理学预测川芎茎叶苯酞提取物(phthalide extract from the stems and leaves of Li-gusticum chuanxiong,SLECX)对缺血性脑卒中(ischemic stroke,IS)的作用机制,并通过氧糖剥夺再灌注(oxygen-glucose deprivation/reoxygenation,OGD/R)模型验证其作用.方法:川芎茎叶经95%乙醇渗漉提取,用X-5大孔树脂纯化,制备SLECX,经超高效液相色谱-四极杆-轨道阱高分辨质谱联用技术(ultra-high-performance liquid chromatography-quadrupole-orbitrap,UHPLC/Q-Orbitrap)分析表征其化学成分.利用 SwissTargetPrediction、Simi-larity ensemble approach网站和GeneCards、TTD以及DisGeNET数据库找到提取物中经鉴定的42个化学成分与IS相关的共同基因.通过STRING网站构建共有靶点的蛋白质-蛋白质相互作用(protein-protein interaction,PPI)网络,并筛选核心靶点.通过Metascape数据库进行GO和KEGG通路富集分析.体外OGD/R诱导的HT22细胞验证SLECX作用及靶点.结果:SLECX中鉴定得到的42个化合物共检索到578个潜在靶标,缺血性脑卒中的疾病基因为3 798个,交集基因367个.涉及的核心靶点有STAT3、HSP90AA1、MAPK1、AKT1、PIK3CA,主要涉及的信号通路有PI3K信号通路、脂质和动脉粥样硬化信号通路等.研究结果显示SLECX能够显著改善OGD/R损伤的HT22细胞形态,提高细胞活力,提高PI3K/Akt信号通路相关蛋白的表达.结论:本研究通过网络药理学与体外验证初步揭示SLECX治疗IS的作用机制,为后期机制深入研究提供参考.

Objective:To predict the mechanism of action of Phthalide extract from the stems and leaves of Ligusticum chuanxiong(SLECX)on ischemic stroke(IS)based on network pharmacology and to verify its effects through an oxygen-glucose deprivation/reperfusion(OGD/R)model.Methods:The stems and leaves of Ligusticum chuanxiong were extracted with 95%ethanol by percola-tion,and the phthalide extract was purified using X-5 macroporous resin.The chemical components were characterized bysis.The com-mon genes related to IS of the 42 identified chemical components in the extract were found by using the SwissTargetPrediction and Simi-larity ensemble approach websites and the GeneCards,TTD and DisGeNET databases.The protein-protein interaction(PPI)network of the common targets was constructed using the STRING website,and core targets were selected.GO and KEGG pathway enrichment an-alyses were conducted through the Metascape database.The effects and targets of SLECX were verified in HT22 cells induced by OGD/R in vitro.Results:A total of 42 compounds identified in SLECX were searched for 578 potential targets,and the disease genes for is-chemic stroke were 3 798,with an intersection of 367 genes.The core targets involved include STAT3,HSP90AA1,MAPK1,AKT1,PIK3CA,and the main signaling pathways involved include the PI3K signaling pathway,lipid and atherosclerosis signaling pathways,etc.The OGD/R model found that SLECX could significantly improve the morphology of HT22 cells,enhance cell viability,and in-crease the expression of proteins related to the PI3K/Akt signaling pathway.Conclusion:This study preliminarily reveals the mecha-nism of action of SLECX in treating IS through network pharmacology and in vitro model validation,providing a reference for further in-depth study of the mechanism.

廖清;邬静;初天哲;李阳;陈胡兰;李罡;谭玉柱

成都中医药大学药学院,四川成都 611137||成都中医药大学中药材标准化教育部重点实验室,四川成都 611137成都中医药大学药学院,四川成都 611137||成都中医药大学中药材标准化教育部重点实验室,四川成都 611137成都中医药大学药学院,四川成都 611137||成都中医药大学中药材标准化教育部重点实验室,四川成都 611137成都中医药大学药学院,四川成都 611137||成都中医药大学中药材标准化教育部重点实验室,四川成都 611137成都中医药大学医学技术学院,四川成都 611137成都中医药大学附属绵阳市中医医院脑病中心,四川绵阳 621053成都中医药大学药学院,四川成都 611137||成都中医药大学中药材标准化教育部重点实验室,四川成都 611137

医药卫生

川芎茎叶苯酞提取物缺血性脑卒中网络药理学PI3K/Akt信号通路

Stems and leaves of Ligusticum chuanxiongPhthalide extractIschemic strokeNetwork pharmacologyPI3K/Akt signa-ling pathway

《成都中医药大学学报》 2026 (5)

19-26,8

国家重点研发计划(2025YFC3509100)国家自然科学基金(82373837)成都中医药大学校院联合创新基金(LH202402011)四川省中医药管理局科技成果转化引导项目(25CGZHZX065)

10.13593/j.cnki.51-1501/r.2026.05.002

评论